Avadel Pharmaceuticals PLC (NASDAQ:AVDL)

7.46
Delayed Data
As of Jun 18
 -0.18 / -2.36%
Today’s Change
6.17
Today|||52-Week Range
11.93
-9.02%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues14.6M172.3M149.8M174.7M
 
 
 
 
 
Cost of Goods Sold975.9K10.3M12.6M15.2M
 
 
 
 
 
Depreciation And Amortization13.9M13.1M14.4M4.9M
 
 
 
 
 
 
Operating ExpensesGross Income-351.6K148.9M122.8M154.6M
 
 
 
 
 
General Expenses37.9M47.1M78.6M93.0M
 
 
 
 
 
Other Operating Expenses22.0M0.000.000.00
 
 
Research And Development22.5M25.5M34.5M33.7M
 
 
 
 
 
Total Operating Expenses74.8M70.4M105.6M113.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-60.2M101.9M44.2M61.5M
 
 
 
 
 
Extraordinary Credit0.000.000.0031.3M
 
 
Extraordinary Charge-59.6M-30.8M-49.1M-2.6M
 
 
 
 
 
Interest Expense On Debt9.1M1.4M960.2K1.1M
 
 
 
 
 
Other Expenses11.7M5.7M-5.4M1.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-116.4M78.0M-9.7M93.4M
 
 
 
 
 
Income Taxes-28.8M-37.5M-31.5M-24.6M
 
 
 
 
 
Discontinued Operations4.0M0.000.000.00
 
 
Net Income-83.6M40.4M-41.2M68.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS36.2M40.6M41.2M40.5M
 
 
 
 
 
Shares To Calculate EPS Diluted36.2M43.6M41.2M41.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.30$0.99-$1.00$1.70
 
 
 
 
 
EPS Diluted-$2.30$0.93-$1.00$1.64